Scienza e Tecnologia
Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer
Medison's platform enables biotech companies to plan, optimize, and launch their breakthrough therapies globally by utilizing Medison's end-to-end, seamless, affiliate-like model through a single, unified, centrally managed partnership.
As Medison continues to scale its operations and deepen partnerships with biotech companies around the world, strengthening its leadership capacity is essential to delivering sustainable value and impact. Shay and Tali bring extensive global experience and strategic insight that will support the company's ability to execute across geographies, navigate increasing complexity, and uphold the highest standards of trust, ethics, and performance.
Shay Tamari , newly appointed Chief Business Officer, will lead Medison's global corporate development strategy. With over 20 years of international experience in the pharmaceutical industry, including a decade at Pfizer and a deep understanding of the U.S. biotech ecosystem, Shay will focus on unlocking long-term growth opportunities, fostering strategic partnerships, and amplifying the reach of Medison's platform. Based in the U.S., Shay brings valuable proximity to major biotech hubs and industry partners.
Tali Mirsky joins as Chief Legal & Compliance Officer, bringing more than 25 years of legal and compliance expertise, in both private and publicly traded companies, most recently from NICE. Her leadership in strategic global transactions, corporate governance, risk management and compliance will support Medison's expansion and further reinforce the integrity of our unique platform, ensuring we uphold the highest standards of governance, compliance, and ethics while operating in diverse international markets.
said Gil Gurfinkel , CEO of Medison.
added Meir Jakobsohn, Founder and Executive Chairman of Medison,
said Shay Tamari , Chief Business Officer.
said Tali Mirsky, Chief Legal & Compliance Officer.
These appointments reflect Medison's commitment to building an unmatched global leadership team to power its platform. With Shay and Tali on board, Medison is further strengthening its ability to help its biotech partners bring breakthrough therapies to more patients, in more places – delivering meaningful impact across regions that have long been underserved.
Medison is redefining global biotech commercialization to change lives.
As the first-of-its-kind unified global commercialization platform, Medison partners with biotech companies to bring breakthrough therapies to patients worldwide, especially those with severe and rare diseases.
We specialize in accelerating access and expanding reach in markets beyond the U.S., Western Europe , and Japan . Our unique affiliate-like model seamlessly integrates commercial, medical, and operational capabilities across diverse regions, enabling biotech innovators to scale globally without compromising on local impact.
By applying creativity, expertise, passion, and a borderless mindset, we're accelerating access to breakthrough therapies—bringing hope to more lives in more places.
We strongly believe that every patient deserves the same chance at a full life, no matter where they live, and we are here to make that belief a reality.
Liat Lavi , VP Corporate Affairs
T: +972-52-6026450
E: liatl@medisonpharma.com
Logo - https://mma.prnewswire.com/media/1527224/MEDISON_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/medison-expands-global-leadership-team-with-chief-business-officer-and-chief-legal--compliance-officer-302485334.html